Bangladesh

in page functions
[French]
Bangladesh
Total population (2017) 164,819,455
Birth cohort (2017) 3,095,451
Surviving Infants (surviving to 1 year per year, 2017) 3,014,717
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 31/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 38/1000
World Bank Index, IDA (2015) 3.31
Gross Nation Income (per capita US$, 2015) 1,190
Co-financing group (2017) Preparatory transition
No. of districts/territories (2016) 64

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Bangladesh

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $560,206,680 $605,106,685 $556,332,397
Cash Support (CASHSUPP) $333,500 $358,500 $333,500 100%
Health system strengthening (HSS 1) $13,671,500 $13,671,500 $13,671,500 100%
Health system strengthening (HSS 2) $22,973,726 $33,922,731 $14,865,680 65%
HepB mono (NVS) $20,224,465 $20,224,465 $20,224,465 100%
HPV Demo (NVS) $724,900 $724,900 $716,562 99%
Immunisation services support (ISS) $23,340,200 $23,340,200 $23,340,200 100%
Injection Safety Devices (NVS) $1,888,000 $2,383,500 $1,809,366 96%
Injection safety support (INS) $6,144,414 $6,144,414 $6,144,414 100%
IPV (NVS) $12,085,810 $12,085,810 $11,400,930 94%
IPV Catch-up RI (NVS) $1,274,500 $1,274,500
Measles (NVS) $9,727,603 $9,727,603 $9,740,021 100%
Measles-Rubella (NVS) $35,781,812 $35,781,812 $35,781,812 100%
MR - Operational costs (OPC) $33,586,500 $33,586,500 $33,586,500 100%
Penta (NVS) $235,012,750 $235,012,750 $235,538,609 100%
Pneumo (NVS) $128,151,000 $161,581,500 $140,864,838 110%
Rotavirus (NVS) $4,275,500 $4,275,500
Vaccine Introduction Grant (VIG) $11,010,500 $11,010,500 $8,314,000 76%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Bangladesh DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 94%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2013) 90.40%
Household survey: DTP3 coverage for female (2013) 92.30%
Household survey: Last DTP3 survey (2013) 91%
% districts achieving > 80% DTP3 coverage (2016) 100%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 94%

Breakdown of support

Non-vaccine support Vaccine support
18% 82%
$100,255,794 $456,076,603

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Bangladesh

24 October 2017

Bangladesh IPV PCV launch 2015

World Polio Day: Gavi's role in polio eradication

24 October marks World Polio Day, when the global community celebrates the immense progress and considers the work ahead to ensure no child suffers from polio again.

29 September 2017

Gavi item

900,000 vaccines 'en route' to Cox's Bazar to prevent cholera

Oral cholera vaccine will protect Rohingya refugees seeking shelter in Bangladesh as well as resident population.

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

close icon

modal window here